SCHEMBL20642766

SCHEMBL20642766

CC(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CCCNC(=O)CC[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FCGRT P55899 1/20 0.52
▸ TUBB4A P04350 5/20 0.51
▸ TUBB P07437 5/20 0.51
▸ TUBA3C P0DPH7 5/20 0.51
▸ TUBA1B P68363 5/20 0.51
▸ TUBA4A P68366 5/20 0.51
▸ TUBB4B P68371 5/20 0.51
▸ TUBB3 Q13509 5/20 0.51
▸ TUBB2A Q13885 5/20 0.51
▸ TUBB8 Q3ZCM7 5/20 0.51
▸ TUBA3E Q6PEY2 5/20 0.51
▸ TUBA1A Q71U36 5/20 0.51
▸ TUBA1C Q9BQE3 5/20 0.51
▸ TUBB6 Q9BUF5 5/20 0.51
▸ TUBB2B Q9BVA1 5/20 0.51
▸ TUBB1 Q9H4B7 5/20 0.51
▸ TSLP Q969D9 2/20 0.48
▸ MC4R P32245 6/20 0.47
▸ FURIN P09958 1/20 0.45
▸ ACE P12821 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20642627 1.00 FCGRT (0.52) FCGRTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20642819 0.93 FCGRT (0.59) FCGRTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13063979 0.91 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL18716924 0.91 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL10308024 0.91 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7861159 0.91 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL18716923 0.91 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL18717033 0.91 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL19473818 0.91 FCGRT (0.50) FCGRTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL19473850 0.91 FCGRT (0.52) FCGRTTUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10179804-B2 Melanocortin receptor-specific peptides PALATIN TECHNOLOGIES, INC. (US) 2019-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179804-B2 Melanocortin receptor-specific peptides MC1R, MC3R, MC5R FCGRT 216/4885TUBB4A 4677/4885TUBB 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback